Skip to main content
OpenTrials
Completed

NCT Number: NCT03968016

Reference Interval Validation of High-Sensitivity Cardiac Troponin T Assay in Thai Population

The investigators aimed to study the cut-off of high sensitivity troponin T using SYSMEX HLSCL Machine in Thai population at percentile 99.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diagnoses Disease

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chulalongkorn University

Pathum Wan, Bangkok, 10330, Thailand

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

For healthy group

Inclusion criteria

  • Group 1: Aged 18 - 40 years
  • Group 2: Aged > 40 - 70 years
  • A presumably healthy population will define from a health questionnaire

Exclusion criteria

  • Heart diseases
  • Renal diseases (CKD or recent AKI)
  • History of pulmonary embolism

For Patient group with stable heart diseases

Inclusion criteria

  • Aged > 40 - 70 years
  • Stable heart disease individuals will be evaluated by cardiologist
  • Non hospitalized (OPD settings)

Exclusion criteria

  • Stable heart diseases with ACS
  • Renal diseases (CKD or recent AKI)
  • History of pulmonary embolism

Treatment and study plan

SYSMEX HLSCL

Device

Diagnostic device

Primary outcomes

  1. Measurement of high sensitivity-troponin T level

    Time frame: 3 days

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
May 30, 2019
Registry last updated
May 30, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.